- WORLD EDITIONAustraliaNorth AmericaWorld
Investing News NetworkYour trusted source for investing success
- Lithium Outlook
- Oil and Gas Outlook
- Gold Outlook Report
- Uranium Outlook
- Rare Earths Outlook
- All Outlook Reports
- Top Generative AI Stocks
- Top EV Stocks
- Biggest AI Companies
- Biggest Blockchain Stocks
- Biggest Cryptocurrency-mining Stocks
- Biggest Cybersecurity Companies
- Biggest Robotics Companies
- Biggest Social Media Companies
- Biggest Technology ETFs
- Artificial Intellgience ETFs
- Robotics ETFs
- Canadian Cryptocurrency ETFs
- Artificial Intelligence Outlook
- EV Outlook
- Cleantech Outlook
- Crypto Outlook
- Tech Outlook
- All Market Outlook Reports
- Cannabis Weekly Round-Up
- Top Alzheimer's Treatment Stocks
- Top Biotech Stocks
- Top Plant-based Food Stocks
- Biggest Cannabis Stocks
- Biggest Pharma Stocks
- Longevity Stocks to Watch
- Psychedelics Stocks to Watch
- Top Cobalt Stocks
- Small Biotech ETFs to Watch
- Top Life Science ETFs
- Biggest Pharmaceutical ETFs
- Life Science Outlook
- Biotech Outlook
- Cannabis Outlook
- Pharma Outlook
- Psychedelics Outlook
- All Market Outlook Reports
Time to Invest in Healthcare Funds, Says The Wall Street Journal
The Wall Street Journal reported on how to reap the benefits of investing in healthcare funds, commenting that the bulk of the uncertainty surrounding the sector has been removed by the presidential election’s affirmation of the Affordable Care Act.
The Wall Street Journal reported on how to reap the benefits of investing in healthcare funds, commenting that the bulk of the uncertainty surrounding the sector has been removed by the presidential election’s affirmation of the Affordable Care Act.
As quoted in the market news:
Health-care mutual funds have gained 19.7% on average in the 12 months through Nov. 15, and are up 12.6% each year over the past three years, according to investment-research firm Morningstar. By comparison, the Standard & Poor’s 500-stock index has gained 10.1% in the 12 months through Nov. 15.
Investors have plowed $4 billion into health and biotechnology funds, including exchange-traded funds, this year through the end of October, according to Lipper. That already is more than double the nearly $1.9 billion the funds took in last year.
The sector should benefit as baby boomers age, says Emerson Bell, a fee-only financial adviser at Halvorson-Boyd & Bell in Dallas who oversees about $50 million in assets. Primary-care physicians will do well under the health-care act, though specialists may suffer a bit, he says. But plenty of entrepreneurs will figure out how to make money under the new rules, he says.
Click here to read the full report from The Wall Street Journal.
Latest News
Investing News Network websites or approved third-party tools use cookies. Please refer to the cookie policy for collected data, privacy and GDPR compliance. By continuing to browse the site, you agree to our use of cookies.